| Unique ID issued by UMIN | UMIN000063589 |
|---|---|
| Receipt number | R000072767 |
| Scientific Title | Registry Study of Esophageal Function Testing and Treatment |
| Date of disclosure of the study information | 2026/11/11 |
| Last modified on | 2026/11/11 10:18:35 |
Registry Study of Esophageal Function Testing and Treatment
Registry Study of Esophageal Function Testing and Treatment
Registry Study of Esophageal Function Testing and Treatment
Registry Study of Esophageal Function Testing and Treatment
| Japan |
Patients with suspected esophageal functional disorders, including esophageal motility disorders and gastroesophageal reflux disease (GERD)
| Hepato-biliary-pancreatic medicine |
Others
NO
This study aims to investigate the associations between objective parameters obtained from high-resolution esophageal manometry (HRM) and 24-hour esophageal pH-impedance monitoring and patient-reported symptoms, including heartburn, chest pain, dysphagia, and globus sensation. Furthermore, this study prospectively evaluates changes in symptoms and diagnostic findings following pharmacological, endoscopic, and surgical treatments, with the goal of contributing to the development of optimal diagnostic and therapeutic strategies for esophageal functional disorders.
Others
To prospectively evaluate the associations between esophageal function test findings and clinical symptoms, as well as changes in symptoms and test findings following treatment.
Exploratory
Others
Not applicable
Associations of esophageal function test parameters with clinical symptoms and therapeutic interventions.
Associations among esophageal function test findings, clinical symptoms, endoscopic findings, gastrointestinal radiographic findings, laboratory parameters, and therapeutic interventions.
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
1.Patients scheduled to undergo high-resolution esophageal manometry (HRM) or 24-hour esophageal pH-impedance monitoring at Keio University Hospital.
2.Patients aged 18 years or older at the time of informed consent.
3.Patients who have received sufficient information about the study and provided written informed consent.
1.Patients who decline to participate in the study.
2.Patients deemed unsuitable for participation by the treating physician.
1500
| 1st name | Hideki |
| Middle name | |
| Last name | Mori |
Keio University School of Medicine
Division of Gastroenterology and Hepatology, Department of Internal Medicine
1608582
35 Shinanomachi, Shinjuku-ku, Tokyo
0333531211
mori-d@keio.jp
| 1st name | Hideki |
| Middle name | |
| Last name | Mori |
Keio University School of Medicine
Division of Gastroenterology and Hepatology, Department of Internal Medicine
1608582
35 Shinanomachi, Shinjuku-ku, Tokyo
0333531211
mori-d@keio.jp
Keio University School of Medicine
Keio University
Other
Keio University School of Medicine Ethics Committee
35 Shinanomachi, Shinjuku-ku, Tokyo
0333531211
med-rinri-ft_pt@adst.keio.ac.jp
NO
| 2026 | Year | 11 | Month | 11 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 08 | Month | 27 | Day |
| 2025 | Year | 11 | Month | 25 | Day |
| 2025 | Year | 11 | Month | 25 | Day |
| 2034 | Year | 12 | Month | 31 | Day |
This is a single-center prospective observational study conducted at Keio University Hospital. Data on esophageal function testing and treatment performed as part of routine clinical practice will be collected. No study-specific therapeutic interventions or treatment allocation will be performed.
| 2026 | Year | 11 | Month | 11 | Day |
| 2026 | Year | 11 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072767